FGFR2 and breast cancer: If overexpression of FGFR2 in breast cancer was related to genotype, it is doubtful whether overexpression of FGFR2 in 12% of tumours, even if only possible on a high risk allele background, would in itself, account for the increase in clinical risk in breast cancer.